Event Title: The 9th Annual Drug Repositioning and Repurposing Conference

ID: 23387

The 9th Annual Drug Repositioning and Repurposing Conference
Arrowhead Publishers
The Westin Arlington Gateway, 801 North Glebe Road, 22203
United States
Event Type
Date of event
21 Sep 2020
Starts on Monday September 21, 2020 at 8:00 am (ends Tuesday September 22, 2020 at 3:00 pm)
Who should attend?
Anybody who is interested
Fees (link)
Industry Early Bird Rate: USD 1395.00, Academic Early Bird Rate: USD 595.00
CPD/CME Points
Summary of event
Join us at the 9TH ANNUAL DRUG REPOSITIONING AND REPURPOSING CONFERENCE in Washington, DC, where attendees will meet and learn from the world's foremost experts in the field or repurposing.
How to register
Additional Information
As the Single Longest-Running Conference in the Space, Arrowhead Publishers' annual event continues to be the "go to" meeting for pharma executives, academicians, researchers and patient advocacy groups who want to keep abreast of new developments in the field, learn from experts and meet possible collaborators and partners. Key Subjects Covered at This Event: Patient Advocacy Efforts Emphasis on and engagement with patient advocacy groups, who are investing in drug repositioning efforts to an unprecedented degree. Cutting-Edge Technologies Artificial intelligence and other technologies are quickly reshaping drug discovery and development. This event will showcase how they are reshaping the field of drug repurposing. New Partnerships The conference will explore how new partnerships between various groups, including government, industry and academia are advancing repurposing. Regulatory and Legal Guidance Legal, IP and regulatory guidance will be shared with the audience, including knowlege and insight into the 505(b)(2) regulatory pathway. Systematic Repositioning and Data Analytics Repurposing is no longer based on serendipity as more and more companies are designing tools to streamline and increase the odds of success. Key Therapeutic Areas for Repurposing Repurposing is beginning to make its mark in a range of therapeutic areas in need of new therapies. Rare and orphan diseases, tropical diseases and cancer will be discussed in terms of repurposing efforts currently underway.
Programme/Speakers (attachment): No attachment